ML and some other firms have current price objectives of $12. That is why we're seeing selling just below that target area. Once it breaks above $12 we should be good to go. Firms will revise their targets upwards as events happen.
Yes Kutz.... Glad some of the good guys on the AMRN Board got in this name, and I just wish
AK would have followed too! Also own DRTX from $7.15 and that one is doing nicely the last few days.
Antibiotics, and bios in general are hot right now! GL to you, and don't sell until $18 or above!